KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Costar (CSGP) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Costar (CSGP) over the last 17 years, with Q3 2025 value amounting to $1.9 billion.

  • Costar's Cash & Equivalents fell 6080.48% to $1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 billion, marking a year-over-year decrease of 6080.48%. This contributed to the annual value of $4.7 billion for FY2024, which is 1025.52% down from last year.
  • Latest data reveals that Costar reported Cash & Equivalents of $1.9 billion as of Q3 2025, which was down 6080.48% from $3.6 billion recorded in Q2 2025.
  • In the past 5 years, Costar's Cash & Equivalents ranged from a high of $5.2 billion in Q3 2023 and a low of $1.9 billion during Q3 2025
  • Over the past 5 years, Costar's median Cash & Equivalents value was $4.7 billion (recorded in 2024), while the average stood at $4.3 billion.
  • As far as peak fluctuations go, Costar's Cash & Equivalents surged by 9141.3% in 2021, and later crashed by 6080.48% in 2025.
  • Quarter analysis of 5 years shows Costar's Cash & Equivalents stood at $3.8 billion in 2021, then grew by 29.81% to $5.0 billion in 2022, then rose by 4.99% to $5.2 billion in 2023, then fell by 10.26% to $4.7 billion in 2024, then plummeted by 58.66% to $1.9 billion in 2025.
  • Its Cash & Equivalents stands at $1.9 billion for Q3 2025, versus $3.6 billion for Q2 2025 and $3.7 billion for Q1 2025.